Category: Federal Forum Posters
Purpose: Veterans are at approximately twice the risk of the general population to experience an opioid related overdose; thus, prevention and risk mitigation strategies are particularly important in the population served by the Veterans Health Administration. The provision of evidence-based information by one health care provider to another to assist in appropriate clinical decision making is defined as academic detailing. The objective of this study is to increase the number of naloxone prescriptions distributed to high-risk veterans on chronic opioid therapy to prevent overdose deaths within our healthcare system through the use of academic detailing.
Methods: This project has been submitted to the non-research determination committee for quality improvement approval. Established Opioid Overdose Education and Naloxone Distribution academic detailing dashboards and risk reports will be utilized to identify eligible veterans for inclusion in the project. Veterans identified in the report as naloxone candidates must have an active, chronic (greater than 90-day duration) opioid prescription, an upcoming appointment with their primary care provider or pharmacy, and cannot be receiving hospice or palliative care. Baseline information will be gathered for all eligible veterans on a priority panel. Data will be retrospectively collected from April 2018 and will continue to be collected until January 2019. The number of naloxone prescriptions offered to veterans by each of the priority providers and pharmacists will be analyzed before and after academic detailing visits have been conducted.
Results: not applicable
Conclusion: not applicable
Leanne Ertle– Pharmacy Resident, Omaha Veteran's Affairs Hospital, Omaha, NE